Tests a nerve device for bowel urgency in ulcerative colitis
Tests a small implanted device that signals a nerve near the tailbone in ulcerative colitis.
Plain-language title generated from the registry record
Registry title: BOOM-IBD2 Pivotal Clinical Trial
Key facts
- Where
- Amarillo, Chapel Hill, Columbia, Folsom, Jackson, Las Vegas, Los Angeles, Manhasset, Mentor, New York, Newport Beach, Palo Alto, Philadelphia, Sioux Falls, St Louis, Waco, Wichita, Wichita Falls, and Woodbury, United StatesSee the 19 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 85 years old?
Source: NCT06571669, who can take part
Where in United States
- Amarillo Premier Research (Objective Health)Amarillo, United StatesTaking people
- UNC- Chapel HillChapel Hill, United StatesTaking people
- Columbia Digestive Health Research (Objective Health)Columbia, United StatesTaking people
- Gastroenterology Medical Clinic (Objective Health)Folsom, United StatesTaking people
- GI AllianceJackson, United StatesTaking people
- Las Vegas Medical Research LLC, DBA Vector Clinical TrialsLas Vegas, United StatesTaking people
- Center for Colorectal InnovationLos Angeles, United StatesTaking people
- Northwell Health North Shore University HospitalManhasset, United StatesTaking people
- Great Lakes GastroMentor, United StatesNo longer taking part
- Columbia University Irving Medical Center/New York Presbyterian HospitalNew York, United StatesTaking people
- Hoag HospitalNewport Beach, United StatesTaking people
- PAMF (Palo Alto Medical Foundation)Palo Alto, United StatesTaking people
- Pennsylvania HospitalPhiladelphia, United StatesNot yet recruiting
- Sanford HealthSioux Falls, United StatesTaking people
- Gateway GI Research (Objective Health)St Louis, United StatesTaking people
- Digestive Research of Central Texas (Objective Health)Waco, United StatesTaking people
- Kansas GastroWichita, United StatesTaking people
- Digestive Health Research of North Texas (Objective Health)Wichita Falls, United StatesNo longer taking part
- MN UrologyWoodbury, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Boomerang Medical
- Trial code
- NCT06571669
- Record updated
- 6 August 2026
- Original description
Ulcerative colitis is a long-lasting condition that causes swelling and sores in the large intestine. This study tests whether a small device placed under the skin can help reduce bowel urgency in people with ulcerative colitis. The investigational device sends mild signals to a nerve near the tailbone. It is placed during a same-day procedure.Read full original descriptionShow less
BOOM-IBD2 Clinical Trial to Evaluate the Effectiveness of Sacral Neuromodulation for the Treatment of IBD.
Ulcerative colitis is a long-lasting condition that causes swelling and sores in the large intestine. This study tests whether a small device placed under the skin can help reduce bowel urgency in people with ulcerative colitis. The investigational device sends mild signals to a nerve near the tailbone. It is placed during a same-day procedure.
Inclusion: Male or female; 18 to 85 years of age; Diagnosed with ulcerative colitis; Ability and willingness to consent to participate by signing the informed consent form; Ability to comply with the protocol and willingness to comply with all follow up requirements.
Exclusion: Fulminant colitis requiring emergency surgery; Previous history of surgery for ulcerative colitis, or probably to require such intervention; Previously implanted with a neurostimulation device or participated in a neurostimulation trial; Any significant medical condition that is likely to interfere with study procedures, device operation, or likely to confound the results of the study; Any psychiatric or personality disorder at the discretion of the study investigator; Any active bacterial infection with a risk of bacteremia or sepsis (e.g. presence of abscess); Active clostridium difficile infection of the colon; Active cytomegalovirus (CMV) infection of the colon; Evidence of colonic perforation; Current evidence of cancer in the gastrointestinal tract; Microscopic, ischemic or infectious colitis; Unresected neoplasia of the colon; Colonic stricture unable to pass a colonoscope; Current participation in another clinical trial; Inability to operate the patient programmer.